Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2025-12-25 @ 7:36 PM
Study NCT ID:
NCT00001832
Status:
COMPLETED
Last Update Posted:
2012-12-21
First Post:
1999-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
990158
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None